I agree with you. Xperience was approved in late April 2021. NXS can only proceed with those important trial runs (evidenced based-in recent investor briefing) that are needed to convince the surgeons only when xperience has been cleared by FDA. The trial runs have not even been completed.
Surely, Xperience can't be sold like pop corn without those trial runs to convince the surgeons.
I agree with you. Xperience was approved in late April 2021. NXS...
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 35.0¢ | 32.0¢ | $72.71K | 212.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20605 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
35.0¢ |
Change
0.020 ( 9.38 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 35.0¢ | 32.0¢ | 46548 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| NXS (ASX) Chart |